The mean age of participants was 54 years, the mean body mass index was 35.5 kg/m, 50 per cent of participants were female and 9.2 per cent had type 2 diabetes
The cost projections for Part B and D are sobering: Part B spending is projected to grow around 6-7% annually over the next decade, driven by an aging population (more doctor visits, etc.), increases in volume and intensity of services, and expensive new technologies (e.g., gene therapies administered under Part B, like new Alzheimers infusions)
B: Histopathological examination of the liver and brain in DV2-infected HepG2-SCID mice with or without antioxidant administration
Peroxisome proliferator activated receptor delta (PPARdelta) agonist but not PPARalpha corrects carnitine palmitoyl transferase 2 deficiency in human muscle cells
The WT-Mcp1-GFP strain was cultured in YPD medium at 30 C and 160 rpm to the log phase
Zhang, S., Liu, H., Yu, H